These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7560688)

  • 21. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B
    Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cystic fibrosis in France in 1988].
    Lenoir G; Simon G; Barbier O; Martin B; Goujard J
    Ann Pediatr (Paris); 1988 Nov; 35(9):623-5. PubMed ID: 3195960
    [No Abstract]   [Full Text] [Related]  

  • 23. Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
    Lagrange-Puget M; Durieu I; Ecochard R; Abbas-Chorfa F; Drai J; Steghens JP; Pacheco Y; Vital-Durand D; Bellon G
    Pediatr Pulmonol; 2004 Jul; 38(1):43-9. PubMed ID: 15170872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
    Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
    Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis mutations with widely variable phenotype: the D1152H example.
    Mussaffi H; Prais D; Mei-Zahav M; Blau H
    Pediatr Pulmonol; 2006 Mar; 41(3):250-4. PubMed ID: 16429425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The Italian registry for cystic fibrosis: what has changed in the last decade].
    Viviani L; Padoan R; Giglio L; Bossi A
    Epidemiol Prev; 2003; 27(2):91-6. PubMed ID: 12848021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acid supplementation in cystic fibrosis.
    Berg U; Kallner A; Kusoffsky E; Strandvik B
    Monogr Paediatr; 1979; 10():1-4. PubMed ID: 460262
    [No Abstract]   [Full Text] [Related]  

  • 28. Low concentrations of sodium and magnesium in erythrocytes from cystic fibrosis heterozygotes.
    Foucard T; Gebre-Medhin M; Gustavson KH; Lindh U
    Acta Paediatr Scand; 1991 Jan; 80(1):57-61. PubMed ID: 2028790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunochemical quantitation of 18 proteins in sera from patients with cystic fibrosis: concentrations correlated to class of fibroblast metachromasia, clinical and radiological lung symptoms.
    Weeke B; Flensborg EW; Jacobsen L; Jorgensen BA; Lykkegaard E; Hoiby N
    Dan Med Bull; 1976 Jun; 23(3):155-60. PubMed ID: 780068
    [No Abstract]   [Full Text] [Related]  

  • 30. Erythrocyte indices in cystic fibrosis.
    Warwick WJ; Hansen LG; Shapiro BG
    Am J Med Technol; 1982 Jun; 48(6):539-42. PubMed ID: 7114086
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fatty acids composition of serum lipid fractions in children with cystic fibrosis of the pancreas before and after treatment with pancreatin].
    Annibaldi L; Antonelli M; Ballati G; Giardini O; Cardi E
    Riv Clin Pediatr; 1968; 81(5):962-4. PubMed ID: 5740224
    [No Abstract]   [Full Text] [Related]  

  • 32. Symptomatic hypomagnesemia in cystic fibrosis.
    Green CG; Doershuk CF; Stern RC
    J Pediatr; 1985 Sep; 107(3):425-8. PubMed ID: 4032136
    [No Abstract]   [Full Text] [Related]  

  • 33. Abnormal electrophoretic mobility of erythrocytes in cystic fibrosis: evidence for a membrane defect.
    Hein J; Seyfarth M; Jenssen HL; Köhler HJ
    Padiatr Grenzgeb; 1985; 24(4):331-40. PubMed ID: 4034213
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antielastase power of the serum in mucoviscidosis of children and in broncho-emphysematous states of adults].
    Brun J; Gilly R; Biot N; Perrin-Fayolle M; Kofman J
    Lyon Med; 1968 Nov; 220(44):1091-106. PubMed ID: 5748396
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of clinical pharmacokinetic services provided to children and adolescents with cystic fibrosis.
    Kearns GL; Jiménez JF; Brown AL; Warren RH
    J Ark Med Soc; 1985 Oct; 82(5):215-9. PubMed ID: 2933385
    [No Abstract]   [Full Text] [Related]  

  • 36. Cimetidine in cystic fibrosis. Effect on steatorrhoea and serum fatty acids.
    Suarez Cortina L; Arranz Pena I; Camarero Salces C; Escobar Castro H
    Acta Paediatr Belg; 1980; 33(1):23-5. PubMed ID: 7405584
    [No Abstract]   [Full Text] [Related]  

  • 37. [Coagulation studies in mucoviscidosis].
    Hein J; Wulff E; Gülzow HU; Wohlfahrt K
    Padiatr Grenzgeb; 1984; 23(4):177-84. PubMed ID: 6483445
    [No Abstract]   [Full Text] [Related]  

  • 38. Ascertainment of CF in Minnesota.
    Warwick WJ; Hansen L
    Minn Med; 1981 Sep; 64(9):553-5. PubMed ID: 7278843
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cystic fibrosis in Puerto Rico].
    Sifontes JE; Rodríguez F; Mayol P; Menéndez R; Alicea E; Vélez W
    Bol Asoc Med P R; 1977 Aug; 69(8):251-7. PubMed ID: 269731
    [No Abstract]   [Full Text] [Related]  

  • 40. Cystic fibrosis in Iraqi children.
    Hassani MA
    J Trop Pediatr Environ Child Health; 1977 Jun; 23(3):136-7. PubMed ID: 586272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.